Syneos Health, Inc. - (SYNH): Price and Financial Metrics
GET POWR RATINGS... FREE!
SYNH POWR Grades
- Growth is the dimension where SYNH ranks best; there it ranks ahead of 99.27% of US stocks.
- SYNH's strongest trending metric is Quality; it's been moving down over the last 179 days.
- SYNH ranks lowest in Quality; there it ranks in the 24th percentile.
SYNH Stock Summary
- SYNH has a market capitalization of $8,609,708,210 -- more than approximately 79.52% of US stocks.
- With a one year PEG ratio of 108.51, Syneos Health Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 79.59% of US stocks.
- SYNH's current price/earnings ratio is 36.66, which is higher than 78.03% of US stocks with positive earnings.
- If you're looking for stocks that are quantitatively similar to Syneos Health Inc, a group of peers worth examining would be ACHC, FLT, RUTH, CGC, and FRGI.
- SYNH's SEC filings can be seen here. And to visit Syneos Health Inc's official web site, go to www.syneoshealth.com.
SYNH Valuation Summary
- SYNH's price/earnings ratio is 40.7; this is 11.51% higher than that of the median Healthcare stock.
- SYNH's price/sales ratio has moved up 0.8 over the prior 83 months.
- SYNH's price/earnings ratio has moved up 70 over the prior 83 months.
Below are key valuation metrics over time for SYNH.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
SYNH | 2021-08-31 | 2 | 3.0 | 40.7 | 36.6 |
SYNH | 2021-08-30 | 2 | 3.0 | 41.0 | 36.8 |
SYNH | 2021-08-27 | 2 | 2.9 | 40.3 | 36.4 |
SYNH | 2021-08-26 | 2 | 2.9 | 40.0 | 36.1 |
SYNH | 2021-08-25 | 2 | 2.9 | 39.9 | 36.1 |
SYNH | 2021-08-24 | 2 | 2.9 | 39.4 | 35.7 |
SYNH Growth Metrics
- The 4 year price growth rate now stands at 17.58%.
- Its 2 year net income to common stockholders growth rate is now at 205.77%.
- Its 3 year cash and equivalents growth rate is now at 101.13%.

The table below shows SYNH's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2021-12-31 | 5,212.97 | 450.278 | 234.831 |
2021-09-30 | 4,979.605 | 378.625 | 250.758 |
2021-06-30 | 4,730.379 | 486.123 | 235.931 |
2021-03-31 | 4,461.167 | 591.188 | 197.937 |
2020-12-31 | 4,415.777 | 425.493 | 192.787 |
2020-09-30 | 4,488.712 | 471.715 | 191.951 |
SYNH's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- SYNH has a Quality Grade of D, ranking ahead of 21.57% of graded US stocks.
- SYNH's asset turnover comes in at 0.618 -- ranking 262nd of 563 Business Services stocks.
- INS, HURN, and MEDP are the stocks whose asset turnover ratios are most correlated with SYNH.
The table below shows SYNH's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.618 | 0.233 | 0.100 |
2021-06-30 | 0.602 | 0.238 | 0.096 |
2021-03-31 | 0.579 | 0.234 | 0.085 |
2020-12-31 | 0.580 | 0.230 | 0.083 |
2020-09-30 | 0.602 | 0.225 | 0.067 |
2020-06-30 | 0.612 | 0.218 | 0.070 |
SYNH Price Target
For more insight on analysts targets of SYNH, see our SYNH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $80.92 | Average Broker Recommendation | 1.33 (Strong Buy) |
SYNH Stock Price Chart Interactive Chart >
SYNH Price/Volume Stats
Current price | $70.91 | 52-week high | $104.18 |
Prev. close | $69.77 | 52-week low | $66.73 |
Day low | $68.98 | Volume | 425,700 |
Day high | $71.34 | Avg. volume | 713,957 |
50-day MA | $76.56 | Dividend yield | N/A |
200-day MA | $87.97 | Market Cap | 7.27B |
Syneos Health, Inc. - (SYNH) Company Bio
Syneos Health, formerly INC Research Holdings, provide the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The company was founded in 2010 and is based in Raleigh, North Carolina.
Latest SYNH News From Around the Web
Below are the latest news stories about Syneos Health Inc that investors may wish to consider to help them evaluate SYNH as an investment opportunity.
Syneos Health, Inc. 2021 Q4 - Results - Earnings Call PresentationNo summary available. |
Syneos Health (SYNH) Q4 Earnings Top Estimates, Margins DownSyneos Health (SYNH) reports better-than-expected earnings for the fourth quarter and strong performances by the Clinical Solutions and Commercial Solutions arms. |
Syneos Health Inc. (SYNH) CEO Alistair Macdonald on Q4 2021 Results - Earnings Call TranscriptSyneos Health Inc. (SYNH) Q4 2021 Results Conference Call February 17, 2022 08:00 AM ET Company Participants Ronnie Speight - SVP, Investor Relations Alistair Macdonald - Chief Executive Officer Jason Meggs - Chief Financial Officer Michael Brooks - Chief Development Officer & Global Head, Clinical Development Solutions Conference Call Participants... |
Triangle’s Syneos Health tops Street earnings due to ‘strong fundamentals,’ CEO says | WRAL TechWireSyneos Health on Thursday morning reported fourth-quarter profit of $76 million, and its CEO cited "strong fundamentals" for a report that beats on earnings despite a slight miss on revenue forecasts. |
Syneos Health tops Street earnings due to ‘strong fundamentals,’ CEO says | WRAL TechWireSyneos Health on Thursday morning reported fourth-quarter profit of $76 million, and its CEO cited "strong fundamentals" for a report that beats on earnings despite a slight miss on revenue forecasts. |
SYNH Price Returns
1-mo | -11.13% |
3-mo | -10.23% |
6-mo | -29.90% |
1-year | -18.61% |
3-year | 68.19% |
5-year | 26.17% |
YTD | -30.94% |
2021 | 50.71% |
2020 | 14.55% |
2019 | 51.14% |
2018 | -9.75% |
2017 | -17.11% |
Continue Researching SYNH
Want to see what other sources are saying about Syneos Health Inc's financials and stock price? Try the links below:Syneos Health Inc (SYNH) Stock Price | Nasdaq
Syneos Health Inc (SYNH) Stock Quote, History and News - Yahoo Finance
Syneos Health Inc (SYNH) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...